Wearable TENS Device Eases Long COVID Symptoms
The transcutaneous electrical nerve stimulation device “offered immediate, on-demand relief,” say researchers.
Tag: COVID-19 and SARS-CoV-2
All
Latest
Wearable TENS Device Eases Long COVID Symptoms
The transcutaneous electrical nerve stimulation device “offered immediate, on-demand relief,” say researchers.
Read More
Impaired Lung Function Linked to Brain Fog in Long COVID
A study using lung and brain MRI shows that lower pulmonary gas exchange in long COVID patients is linked to cognitive dysfunction.
Read More
Surprising Age Groups Have the Worst Long COVID Symptoms
A new study from Northwestern Medicine finds symptoms occurred regardless of mild or severe COVID-19 infection.
Read More
FDA Lifts Clinical Hold on Novavax’s COVID-Flu Vaccine Trial
The FDA removed the clinical hold on Novavax’s COVID-19-influenza combination vaccine, allowing the company to proceed with its planned phase 3 trial.
Read More
EPA Updates Indoor Air Quality Guidance
The EPA has released updated guidance on indoor air quality strategies for preventing the spread of common respiratory viruses.
Read More
Philips to Expand AI for Early Infection Detection Within Department of Defense
After successful development and pilot, technology using biomarkers from wearables to predict infection is set to expand within the US Department of Defense.
Read More
New CMS Rule Requires Weekly Respiratory Data Reporting from Hospitals
Starting Nov 1, Medicare- and Medicaid-participating hospitals must report COVID-19, influenza, and RSV data to the CDC on a weekly basis.
Read More
CDC Recommends Extra COVID-19 Shot for Seniors and High-Risk Groups
The CDC now recommends a second COVID-19 vaccine dose for people aged 65 and older, as well as those who are immunocompromised, six months after their initial dose.
Read More
Mild COVID-19 in Pregnancy May Trigger Fetal Inflammation
A protein made by SARS-CoV-2 can pass through the placenta and cause serious inflammatory immune responses in the developing fetus for 66% of pregnancies.
Read More
FDA Places Hold on Novavax’s COVID-Flu Vaccine IND After Adverse Event
The FDA has placed a hold on Novavax’s Investigational New Drug application for its COVID-19-influenza combination and stand-alone influenza vaccines following a report of an adverse event in a participant from the completed combination trial.
Read More
COVID-19 Raises Heart Attack, Stroke Risk for Up to Three Years
Individuals infected with COVID-19 early in the pandemic faced an increased risk of heart attack, stroke, and death for up to three years following initial infection.
Read More
FDA Authorizes Home Flu and COVID-19 Combination Test
The test, for use without a prescription, marks the first flu/COVID-19 test to be authorized outside of emergency use authorities.
Read More
Sepsis Cases Rise 72% Driven by Pandemic
The COVID-19 pandemic led to a noticeable rise in sepsis-related hospitalizations, hospital costs, and in-hospital mortality, particularly for patients with a COVID-19 diagnosis.
Read More
Pneumonia: Etiology, Care and Prevention
Pneumonia is a potentially life-threatening infection of the lungs that inflames alveoli and spurs the overproduction of purulent material. Typically afflicting neonates and seniors, the COVID pandemic has revealed the importance of proper pneumonia care for all patients.
Read More
Why Aren’t Some Long COVID Patients’ Lungs Healing?
A new study reveals that immune cells, typically involved in lung repair, may instead drive persistent damage and fibrosis in COVID patients, preventing proper healing.
Read More
Oral COVID-19 Drug Candidate Ratutrelvir Shows Promise in Early Trial
Topline results demonstrated that the drug was well-tolerated over a 10-day period and achieved consistent plasma levels without the need for ritonavir co-administration.
Read More
NIH Panel Provides Final COVID-19 Treatment Recommendations
Future updates to COVID-19 treatment recommendations will transition to professional medical societies.
Read More
COVID-19 Recovery Boosts Immune Defense Against Flu
Recovering from COVID-19 may strengthen the immune system’s response to other viruses like the flu by creating lasting memory in certain immune cells, a new study suggests.
Read More
Veklury Recalled Due to Risk of Glass Particle Contamination
Gilead has recalled one lot of Veklury (remdesivir) after confirming the presence of a glass particle in a vial following a customer complaint.
Read More
Metformin May Protect Against Long COVID in Diabetics
NIH-backed research reveals diabetics taking metformin have a lower risk of developing long COVID or dying after infection compared to those on other diabetes medications.
Read More
Arthritis Drugs Could Treat Persistent COVID Lung Complications
New research suggests that existing FDA-approved medications may help treat lingering lung complications caused by COVID-19 by disrupting harmful immune responses.
Read More
Opaganib Reduces Mortality in Hospitalized COVID-19 Patients
Data from a post hoc analysis of a phase 2/3 study of oral opaganib in COVID-19 pneumonia showed a 62% reduction in mortality and a 21% improvement in time to room air.
Read More
COVID-19, Flu and RSV Shots − An Epidemiologist Explains Why All Three Matter This Fall
Epidemiologist Annette Regan explains why officials recommend that people get these shots over the coming months.
Read More
FDA Authorizes Updated Novavax COVID-19 Vaccine
The FDA has granted emergency use authorization for an updated Novavax COVID-19 vaccine targeting current variants.
Read More